ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Activity

28 hedge funds and large institutions have $14.3M invested in Eledon Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
8
Closed
5
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$42K

Top Buyers

1
Ensign Peak Advisors
Ensign Peak Advisors
Utah
$1.03M
2
UBS Group
UBS Group
Switzerland
$9.1K
3
BlackRock
BlackRock
New York
$118K
4
TRCT
Tower Research Capital (TRC)
New York
$4K
5
Vanguard Group
Vanguard Group
Pennsylvania
$1.55M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
2
Two Sigma Advisers
Two Sigma Advisers
New York
$58.4K
3
CM
CM Management
Florida
$535K
4
Two Sigma Investments
Two Sigma Investments
New York
$49.3K
5
CAM
Cormorant Asset Management
Massachusetts
$2.78M
Name Holding Trade Value Shares
Change 		Shares
Change %
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$42 – +4 +0%
Bank of America
27
Bank of America
North Carolina
$32 +$32 +14 New
Morgan Stanley
28
Morgan Stanley
New York
$2 -$2.26K -1,132 -100%
Point72 Asset Management
29
Point72 Asset Management
Connecticut
– -$1.04M -375,000 Closed
SWM
30
Spire Wealth Management
Virginia
– -$1K -500 Closed
Federated Hermes
31
Federated Hermes
Pennsylvania
– -$1K -339 Closed
1
2